Harold Bernstein, President, R&D & CMO: Maze Therapeutics MAZE Sell · Filed 04/02

Trade details

Type: Insider sale
Amount: $331,932.48
Shares · price: 11,352 sh · $29.24 a share
Held after: 3,648 sh
Stock: Maze Therapeutics MAZE
Person: Harold BernsteinPresident, R&D & CMO
Trade date: 26/04/01
Filed: 26/04/02
Days to filing: 1 days

Sold 75.7% of holdings

Share of holding sold: 75.7%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Harold Bernstein's recent trades

Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$251.1K
9,705 sh
$251.1K
Filed 09/04
Traded 09/04
Harold BernsteinPresident, R&D & CMO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$283.5K
10,685 sh
$283.5K
Filed 09/02
Traded 09/02
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1.4M
46,892 sh
$1.4M
Filed 07/01
Traded 07/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$338.9K
13,253 sh
$338.9K
Filed 06/03
Traded 06/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$42.2K
1,600 sh
$42.2K
Filed 06/03
Traded 06/01